Use of dihydro-isobenzofuran in combination with serotonin reuptake inhibitors for CNS disease e.g. depression, anxiety, bipolar disorder, obsessive compulsory disorder
Research output: Patent
Standard
Use of dihydro-isobenzofuran in combination with serotonin reuptake inhibitors for CNS disease e.g. depression, anxiety, bipolar disorder, obsessive compulsory disorder. / Bøgesø, Klaus P (Inventor); Juhl, K (Inventor); Zhong, H (Inventor); Løland, Claus Juul (Inventor).
Patent No.: WO2013110313-A1.Research output: Patent
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - PAT
T1 - Use of dihydro-isobenzofuran in combination with serotonin reuptake inhibitors for CNS disease e.g. depression, anxiety, bipolar disorder, obsessive compulsory disorder
AU - Bøgesø, Klaus P
AU - Juhl, K
AU - Zhong, H
AU - Løland, Claus Juul
PY - 2013
Y1 - 2013
N2 - NOVELTY - For treatment of a CNS disease in a patient, dihydro-isobenzofuran compound (I) in combination with serotonin reuptake inhibitor, is used.USE - For treatment of CNS disease (claimed) including depression, anxiety, bipolar disorder, obsessive compulsory disorder, post traumatic stress disorder and social anxiety disorder.ADVANTAGE - The compound (I) potentiates the effect of compound that inhibits serotonin reuptake; and selectively modulates the allosteric site at the serotonin transporter.DETAILED DESCRIPTION - For treatment of a CNS disease in a patient, dihydro-isobenzofuran compound of formula (I) in combination with serotonin reuptake inhibitor, is used.
AB - NOVELTY - For treatment of a CNS disease in a patient, dihydro-isobenzofuran compound (I) in combination with serotonin reuptake inhibitor, is used.USE - For treatment of CNS disease (claimed) including depression, anxiety, bipolar disorder, obsessive compulsory disorder, post traumatic stress disorder and social anxiety disorder.ADVANTAGE - The compound (I) potentiates the effect of compound that inhibits serotonin reuptake; and selectively modulates the allosteric site at the serotonin transporter.DETAILED DESCRIPTION - For treatment of a CNS disease in a patient, dihydro-isobenzofuran compound of formula (I) in combination with serotonin reuptake inhibitor, is used.
M3 - Patent
M1 - WO2013110313-A1
ER -
ID: 137375992